Guangdong, China

Hong Ouyang

USPTO Granted Patents = 1 


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Corneal Stem Cell Research by Inventor Hong Ouyang

Introduction

Hong Ouyang is an innovative inventor based in Guangdong, China, known for his significant contributions to the field of ophthalmology. His groundbreaking work focuses on the culturing and differentiation of corneal limbal stromal stem cells, providing new avenues for treatments involving corneal injuries.

Latest Patents

Ouyang holds a patent titled "Methods of serum-free culturing corneal limbal stromal stem cells and inducing sphere formation and differentiation in vitro." This patent presents a method for culturing corneal limbal stromal stem cells without the use of serum, which is essential for maintaining the cells' stemness and specificity. The serum-free medium he developed ensures adequate nutrients and an optimal environment for cell growth, making it highly beneficial for both experimental studies and clinical applications in corneal cell therapy.

Career Highlights

Hong Ouyang works at the Zhongshan Ophthalmic Center, affiliated with Sun Yat-sen University, where he has been instrumental in driving forward research in ocular health and regenerative medicine. His research aims to improve methodologies relating to corneal limbal stromal stem cells, ultimately contributing to advances in cell therapy for corneal lesions and transplants.

Collaborations

During his research endeavors, Ouyang has collaborated with notable colleagues, including Liqiong Zhu, further enhancing the depth and scope of his work in stem cell research. Their combined efforts have been pivotal in developing new methods and understanding the therapeutic potential of corneal stem cells.

Conclusion

Hong Ouyang's innovations in the field of corneal limbal stromal stem cells are paving the way for new treatment options in regenerative medicine. With his single patent and ongoing research, he continues to advance our understanding of stem cell biology, providing hope for patients suffering from corneal injuries. His dedication to improving ocular health through scientific innovation is commendable and essential in the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…